Kronos Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kronos Bio generated cash of -$78,582,000, which is more than the previous year. Cash used in financing activities reached the amount of $567,000 last year. Net change in cash is therefore -$11,647,000.
Cash Flow
| 2018 | -6.44M | -1.07M | 16.21M |
|---|---|---|---|
| 2019 | -15.08M | -67.58M | 105.00M |
| 2020 | -37.91M | -160.23M | 415.61M |
| 2021 | -117.92M | 63.72M | 4.46M |
| 2022 | -90.92M | -32.22M | 851K |
| 2023 | -78.58M | 66.36M | 567K |
KRON Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 77.99M | 200.29M | 250.03M | 32.57M | 10.22M | 1.52M |
Operating activities | ||||||
Net income | -112.67M | -133.20M | -151.07M | -88.44M | -16.11M | -6.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.13M | 2.26M | 1.97M | 839K | 356K | 91K |
Stock-based compensation expense | 24.98M | 31.14M | 26.21M | 3.75M | 113K | 0 |
| Deferred income tax benefit | 24.98M | 31.14M | 26.21M | 3.75M | 113K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -4.14M | 4.02M | -3.19M | 2.80M | 716K | -28K |
Cash generated by operating activities | -78.58M | -90.92M | -117.92M | -37.91M | -15.08M | -6.44M |
Investing activities | ||||||
Purchases Of Investments | -212.95M | -367.12M | -177.73M | -229.32M | -64.63M | 0 |
Investments In Property Plant And Equipment | -679K | -577K | -4.26M | -9.56M | -2.94M | -1.07M |
Acquisitions Net | 0 | 31.64M | -67.98M | 150.66M | 0 | 0 |
Cash generated by investing activities | 66.36M | -32.22M | 63.72M | -160.23M | -67.58M | -1.07M |
Financing activities | ||||||
Common Stock Issued | 567K | 851K | 4.46M | 263.72M | 115K | 5K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 538K | 380K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -5K | -32K | -30K | -72K |
Cash used in financing activities | 567K | 851K | 4.46M | 415.61M | 105.00M | 16.21M |
Net Change In Cash | -11.64M | -122.29M | -49.74M | 217.46M | 22.34M | 8.70M |
Cash at end of period | 66.35M | 77.99M | 200.29M | 250.03M | 32.57M | 10.22M |
| Data source | Data source | Data source | Data source |